Newsroom

SHANGHAI--(BUSINESS WIRE)--Robbyant, an embodied AI company within Ant Group, today open-sourced LingBot-Depth, a high-precision spatial perception model designed to enhance robots’ depth sensing and 3D environmental understanding capabilities in complex real-world environments. In parallel, Robbyant announced a plan to form a strategic partnership with Orbbec, a leading provider of robotics and AI vision. As part of this collaboration, Orbbec will integrate LingBot-Depth into its next-generati...

ABU DHABI, United Arab Emirates--(BUSINESS WIRE)--Ohana Development and Manchester City F.C. Sign Agreement to Launch Multi-Billion-Dirham Project in Abu Dhabi...

DUBLIN--(BUSINESS WIRE)--Cirium Ascend Consultancy has been named Appraiser of the Year 2026 in the Airline Economics Aviation 100 Global Leaders Awards, the team’s 11th title in 15 years. The Consultancy is a highly respected division of Cirium, the world’s most trusted source of aviation analytics. The Appraiser of the Year award recognizes the aircraft appraisal provider that has demonstrated the greatest contribution to the industry over the past year. The fourth consecutive win reflects th...

PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, obtains both marketing authorization (MA) and reimbursement status for its drug Sibnayal® (fixed combination of potassium citrate and potassium bicarbonate) in the United Arab Emirates (UAE) for the treatment of distal Renal Tubular Acidosis (dRTA). This M...

PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), société pharmaceutique spécialisée dans le développement et la commercialisation de traitements innovants pour les personnes souffrant de maladies rénales rares, annonce l’obtention concomitante de l’autorisation de mise sur le marché (AMM) et du remboursement de son médicament Sibnayal® (combinaison fixe de citrate et de bicarbonate de potassium) aux Emirats Arabes Unis, dans le traitement de l’Aci...

LUXEMBOURG & BRUSSELS & LIEGE, Belgium--(BUSINESS WIRE)--SamanTree Medical, a European leader in surgical imaging innovation, has secured €20 million in financing from the European Investment Bank (EIB). The operation is backed by InvestEU, the EU’s flagship program to mobilize over €372 billion in additional investment from 2021 to 2027. The financing supports the development of an advanced confocal microscopy scanner for rapid imaging of the internal microstructure of tissue samples during su...

NEW YORK--(BUSINESS WIRE)--SpotDraft secures investment from Qualcomm Ventures to expand AI-powered contract lifecycle management for enterprise legal teams....

AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced an application of its proprietary HYFT® technology designed to identify functional adjacency - meaning different molecules can produce the same therapeutic effect even when sequence comparisons suggest they are unrelated - an emerging source of competitive, legal, and valuation risk in modern drug discovery that sequenc...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Wealthfront Corporation (“Wealthfront” or the “Company”) (NASDAQ:WLTH) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On December 12, 2025, Wealthfront completed its Initial Public Offering (“IPO”) of 34,615,384 shares of co...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Lightmatter, the leader in photonic (super) computing, today announced a strategic collaboration with Synopsys, the leader in engineering solutions from silicon to systems, to integrate Synopsys 224G SerDes and UCIe IP for 3nm process into the Lightmatter’s Passage™ 3D Co-Packaged Optics (CPO) platform. Through this collaboration, Lightmatter is developing a robust, low-latency CPO platform designed to scale to next-generation AI infrastructure, optimizin...